FERROGRAD FOLIC

This brand name is authorized in Austria, Ireland, Israel, Malta, New Zealand, United Kingdom

Active ingredients

The drug FERROGRAD FOLIC contains a combination of these active pharmaceutical ingredients (APIs):

1 Iron(II) sulfate UNII 39R4TAN1VT - FERROUS SULFATE

Iron sulphate is a co-factor of various enzymes necessary for the transfer of energy (eg. cytochrome oxidase, xanthine oxidase). Iron is also present in hemoglobin and myoglobin, which are essential for the transport and use of oxygen. Read about Ferrous sulfate

2 Folic acid UNII 935E97BOY8 - FOLIC ACID

Folic acid is a member of the vitamin B group which is reduced in the body to tetrahydrofolate, a co-enzyme active in several metabolic processes and produces a haemopoietic response in nutritional megaloblastic anaemias. Folic acid is rapidly absorbed and widely distributed in body tissues. Read about Folic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B03AD03	Ferrous sulfate and folic acid	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AD Iron in combination with folic acid
Discover more medicines within B03AD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 23851
Country: IE	Health Products Regulatory Authority	Identifier(s): 25275
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 1099
Country: MT	Medicines Authority	Identifier(s): AA1438/07102, AA521/00106, AA770/14701
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1501